{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "01057915",
    "validDate": "2028-04-26 00:00:00.000",
    "issueDate": "2013-04-26 00:00:00.000",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHY00105791502",
    "prodNameC": "利伏抗膜衣錠100毫克",
    "prodNameE": "Leevk F.C. Tablets 100mg",
    "indicationsName": [
        "治療正值急性轉化期(blast crisis)、加速期或經ALPHA-干擾素治療無效之慢性期的慢性骨髓性白血病(CML)患者。治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷為慢性骨髓性白血病(CML)的病人。\r\n治療初診斷為費城染色體陽性急性淋巴性白血病(Ph+ ALL)且併用化療之成年及兒童患者。\r\n做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病(Ph+ ALL)之單一療法。\r\n治療患有與血小板衍生生長因子受體(PDGFR)基因重組相關之骨髓發育不全症候群(MDS)\/骨髓增生性疾病(MPD)之成人患者。\r\n治療患有系統性肥大細胞增生症(SM)，限具FIP1L1-PDGFR基因變異且不具有c-Kit基因D816V突變之成人患者。\r\n治療嗜伊紅性白血球增加症候群(HES)與\/或慢性嗜伊紅性白血病(CEL)且有血小板衍生生長因子受體(PDGFR)基因重組之成人患者。\r\n作為成人KIT(CD 117)陽性胃腸道基質瘤完全切除後（complete gross resection）之術後輔助治療。\r\n治療無法手術切除、復發性或轉移性且有血小板衍生生長因子受體(PDGFR)基因重組之隆突性皮膚纖維肉瘤(DFSP)之成人患者。\r\n"
    ],
    "does": "1116",
    "packageUnit": [
        {
            "packageSpec": "2-1000錠",
            "packageUnit": "A3"
        },
        {
            "packageSpec": "2-1000錠",
            "packageUnit": "89"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": null,
    "ingredientsDesc": [
        "IMATINIB MESYLATE"
    ],
    "restraintItemsCode": [
        "01",
        "24",
        "61"
    ],
    "applicantName": "中國化學製藥股份有限公司新豐工廠",
    "applicantAddr": "新竹縣新豐鄉坑子口182之1號",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "中國化學製藥股份有限公司新豐工廠",
            "factoryAddr": "新竹縣新豐鄉坑子口１８２之１號",
            "factoryCompanyAddr": "",
            "countryCode": "TW",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "0402602300",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013000710",
            "ingredientsDesc": "IMATINIB MESYLATE",
            "concentDesc": "(eq. to Imatinib 100mg)",
            "concent": "119.5000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [
        {
            "licChgDocId": "DB8CB6BF-C4E4-4D28-A1CC-00C51B7460F5",
            "approvedDocNo": "1129068686",
            "approvedDate": "2023-12-28",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "906C4EB8-C4CC-430E-AF1A-FB0B80AB46AF",
            "approvedDocNo": "9999999999",
            "approvedDate": "2022-01-22",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "3415DC73-01F0-4E1A-9AD7-5506A9DD97E1",
            "approvedDocNo": "1106019794",
            "approvedDate": "2021-09-08",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "FA287BFC-2E65-4258-8A58-B2CA9B5E6394",
            "approvedDocNo": "1106019794",
            "approvedDate": "2021-09-08",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "051A8F9A-3D20-411C-B819-F3FFC84EBB92",
            "approvedDocNo": "1106019794",
            "approvedDate": "2021-09-08",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        }
    ],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EA01"
        }
    ],
    "licBaseId": "FF336C4C-EC88-4760-A890-9F20E76E908B"
}